Sign Up
NEWSROOM
We are data-driven and are focused on contributing to research and treatments for unmet medical needs
Recent News
Apr 25, 2024
Read More
Apr 23, 2024
Apr 22, 2024
Select News Releases
All News
25
Apr
INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq ...
23
INmune Bio Inc. Announces 24-Month Stability Validation of XPro™ for Phase III Readiness and Comme...
22
INmune Bio Inc. Raises Approximately $4.8 Million in Gross Proceeds Through Registered Direct Offeri...
08
INmune Bio Inc. Presents Data on INB03’s Role as an Immune Check Point Modulator in the Treatment ...
28
Mar
INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update...
26
INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Th...
13
INmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives The ISCT Career Achievement Award in Cell...
05
INmune Bio Reports Significant EEG Improvement in Alzheimer’s Patients Treated with XPro™...
12
Feb
INmune Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference...
06
INmune Bio to Participate in Baird’s Biotech Discovery Series Webcast on February 13, 2024...
30
Jan
INmune Bio: FDA Removes Clinical Hold For Alzheimer's Disease Program...
02
INmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune™ in Patients with Metasta...
Subscribe to receive the latest updates